| 肾素-血管紧张素系统抑制药和糖尿病 |
| |
| 引用本文： | 黄震华. 肾素-血管紧张素系统抑制药和糖尿病[J]. 中国新药与临床杂志, 2011, 0(1) |
| |
| 作者姓名： | 黄震华 |
| |
| 作者单位： | 上海交通大学医学院附属第九人民医院心血管病研究室; |
| |
| 摘 要： | 血管紧张素转换酶抑制药(ACEI)和血管紧张素Ⅱ受体1拮抗药(ARB)是目前抑制肾素-血管紧张素系统的主要药物大量研究结果表明ACEI和ARB不仅可降低糖尿病的发生率、延迟糖尿病的进展,而且可降低糖尿病患者心血管事件的发生率和心血管死亡率。本文对其作用及机制进行探讨
|
| 关 键 词： | 血管紧张素转换酶抑制药 血管紧张素Ⅱ1型受体拮抗剂 糖尿病 |
Renin-angiotensin system blockade and diabetes meilitus |
| |
| HUANG Zhen-hua. Renin-angiotensin system blockade and diabetes meilitus[J]. Chinese Journal of New Drugs and Clinical Remedies, 2011, 0(1) |
| |
| Authors: | HUANG Zhen-hua |
| |
| Affiliation: | HUANG Zhen-hua (Cardiovascular Research Room,the Ninth People's Hospital,Medical College,Shanghai Jiaotong University,SHA NGHA I 200011,China) |
| |
| Abstract: | Angiotensin converting enzyme inhibitors(ACEI) and angiotensinⅡreceptor 1 blockers (ARB) are main drugs for inhibiting rennin-angiotensin system nowadays.A large amount of studies showed that ACEI and ARB not only decreased the occurrence of diabetes mellitus and delayed the progression of diabetes mellitus,but also decreased the occurrence of cardiovascular events and cardiovascular death.The reactions and mechanisms of these are discussed in this paper. |
| |
| Keywords: | angiotensin converting enzyme inhibitors angiotensinⅡtype 1 receptor blockers diabetes mellitus |
| 本文献已被 CNKI 等数据库收录！ |
